Patents by Inventor Tohru Miyazaki

Tohru Miyazaki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200385346
    Abstract: The present invention provides a heterocyclic compound having an orexin type 2 receptor agonist activity. A compound represented by the formula (I): wherein each symbol is as described in the specification, or a salt thereof, has an orexin type 2 receptor agonist activity, and is useful as an agent for the prophylaxis or treatment of narcolepsy.
    Type: Application
    Filed: August 2, 2018
    Publication date: December 10, 2020
    Applicant: Takeda Pharmaceutical Company Limited
    Inventors: Tatsuhiko FUJIMOTO, Kentaro RIKIMARU, Koichiro FUKUDA, Hiromichi SUGIMOTO, Takahiro MATSUMOTO, Yuichi KAJITA, Satoshi MIKAMI, Yuhei MIYANOHANA, Tatsuki KOIKE, Masaki DAINI, Masaki OGINO, Kohei TAKEUCHI, Tohru MIYAZAKI, Yoshiteru ITO, Norihito TOKUNAGA, Takahiro SUGIMOTO, Tsuneo ODA, Yasutaka HOASHI, Yasushi HATTORI, Keisuke IMAMURA
  • Patent number: 10828717
    Abstract: A lap welding method of a steel sheet includes spot welding in a state in which the flange portion of a second steel sheet member having the flange portion and a standing wall portion is overlapped with the first steel sheet member, thereby forming a nugget between a first steel sheet member and a flange portion; and, after the spot welding, laser welding a region between an R stop of the standing wall portion and the nugget, thereby forming a weld bead, and, in the weld bead, a length dimension is equal to or longer than a diameter of the nugget, and a width dimension is 0.5 to 3.0 mm.
    Type: Grant
    Filed: September 16, 2016
    Date of Patent: November 10, 2020
    Assignee: NIPPON STEEL CORPORATION
    Inventors: Seiji Furusako, Tohru Okada, Koichi Sato, Yasunobu Miyazaki
  • Publication number: 20200247747
    Abstract: The present invention provides a heterocyclic compound having an orexin type 2 receptor agonist activity. A compound represented by the formula (I): wherein each symbol is as described in the specification, or a salt thereof has an orexin type 2 receptor agonist activity, and is useful as an agent for the prophylaxis or treatment of narcolepsy.
    Type: Application
    Filed: January 30, 2020
    Publication date: August 6, 2020
    Applicant: Takeda Pharmaceutical Company Limited
    Inventors: Yasushi Hattori, Yuhei Miyanohana, Yuichi Kajita, Tatsuki Koike, Yasutaka Hoashi, Norihito Tokunaga, Alexander Martin Pawliczek, Tsuneo Oda, Tohru Miyazaki, Yoshiteru Ito, Kohei Takeuchi, Keisuke Imamura, Takahiro Sugimoto
  • Patent number: 10734854
    Abstract: A rotor includes a rotary shaft having a non-magnetic body, a plurality of rotor cores, and a plurality of permanent magnets disposed between the plurality of rotor cores, wherein a concave section extending in an axial direction is formed in any one of the non-magnetic body and a base end of the rotor core, and a convex section fitted into the concave section is formed at the other, the concave section is formed by a key groove section and a dovetail groove section in communication with each other, the convex section is formed by a key section configured to fit into the key groove section and a dovetail protrusion configured to fit into the dovetail groove section, the key section and the dovetail protrusion being integrally formed with each other, and a gap is formed between the dovetail groove section and the dovetail protrusion in the circumferential direction.
    Type: Grant
    Filed: April 27, 2017
    Date of Patent: August 4, 2020
    Assignees: MITSUBA CORPORATION, HONDA MOTOR CO., LTD.
    Inventors: Yosuke Fujii, Tohru Yumoto, Taichi Yamamoto, Susumu Miyazaki
  • Patent number: 10722935
    Abstract: Provided is a mechanical joining apparatus enabling stable riveting when joining metal sheets even when the sheets are large in deformation resistance, the apparatus comprising a punch and die, blank holder and power device, wherein the punch and die are arranged facing each other, the holder is configured by an electrode material able to push against and electrically heat the sheets by one end of the holder, the punch is comprised of a material able to drive in a rivet, the die is comprised of an electrode material able to support and electrically heat the sheets, and the power device is configured to start supply of current through the holder and die so as to raise the temperature of the sheets at the same time as the start of driving in of the rivet and to continue to supply current until the end of driving in of the rivet.
    Type: Grant
    Filed: July 1, 2016
    Date of Patent: July 28, 2020
    Assignee: NIPPON STEEL CORPORATION
    Inventors: Seiji Furusako, Tohru Okada, Yasunobu Miyazaki, Fuminori Watanabe, Yoshiaki Nakazawa
  • Publication number: 20200207734
    Abstract: The present invention provides a heterocyclic compound having an orexin type 2 receptor agonist activity. A compound represented by the formula (I): wherein each symbol is as described in the specification, or a salt thereof, is useful as an agent for the prophylaxis or treatment of narcolepsy.
    Type: Application
    Filed: August 2, 2018
    Publication date: July 2, 2020
    Applicant: Takeda Pharmaceutical Company Limited
    Inventors: Yuichi KAJITA, Satoshi MIKAMI, Yuhei MIYANOHANA, Tatsuki KOIKE, Masaki DAINI, Norio OYABU, Masaki OGINO, Kohei TAKEUCHI, Yoshiteru ITO, Norihito TOKUNAGA, Takahiro SUGIMOTO, Tohru MIYAZAKI, Tsuneo ODA, Yasutaka HOASHI, Yasushi HATTORI, Keisuke IMAMURA
  • Publication number: 20200207715
    Abstract: The present invention provides a heterocyclic compound having an orexin type 2 receptor agonist activity. A compound represented by the formula (I): wherein each symbol is as described in the specification, or a salt thereof, is useful as an agent for the prophylaxis or treatment of narcolepsy.
    Type: Application
    Filed: March 6, 2020
    Publication date: July 2, 2020
    Applicant: Takeda Pharmaceutical Company Limited
    Inventors: Yuichi Kajita, Yuhei MIYANOHANA, Tatsuki KOIKE, Kohei TAKEUCHI, Yoshiteru ITO, Norihito TOKUNAGA, Takahiro SUGIMOTO, Tohru MIYAZAKI, Tsuneo ODA, Yasutaka HOASHI, Yasushi HATTORI, Keisuke IMAMURA
  • Patent number: 10603713
    Abstract: Provided is a mechanical joining apparatus enabling reduction of breakage of the area around a rivet of a joint obtained by riveting, the apparatus comprising a punch and die, blank holder, first power device, second power device and cooling device, wherein the first power device is configured to start supply of current through the holder and die so as to raise the temperature of the sheets before the punch drives in the rivet, the second power device is configured to start supply of current through the punch and die so as to supply current through and heat treat the rivet after the punch drives in the rivet, and the cooling device is connected to the punch and is configured to cool the rivet after the rivet is heat treated.
    Type: Grant
    Filed: July 1, 2016
    Date of Patent: March 31, 2020
    Assignee: NIPPON STEEL CORPORATION
    Inventors: Seiji Furusako, Tohru Okada, Yasunobu Miyazaki, Fuminori Watanabe, Yoshiaki Nakazawa
  • Patent number: 10584097
    Abstract: The present invention provides a heterocyclic compound having an orexin type 2 receptor agonist activity. A compound represented by the formula (I): wherein each symbol is as described in the specification, or a salt thereof, is useful as an agent for the prophylaxis or treatment of narcolepsy.
    Type: Grant
    Filed: September 20, 2019
    Date of Patent: March 10, 2020
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Yuichi Kajita, Yuhei Miyanohana, Tatsuki Koike, Kohei Takeuchi, Yoshiteru Ito, Norihito Tokunaga, Takahiro Sugimoto, Tohru Miyazaki, Tsuneo Oda, Yasutaka Hoashi, Yasushi Hattori, Keisuke Imamura
  • Publication number: 20200066251
    Abstract: A message management unit receives and accumulates a message, wherein the message is distributed for every update, is the message data representing a latest situation of a competition, an explanation generation unit generates an explanatory text for conveying unconveyed information detected from the message, based on conveyed information, a speech synthesis unit outputs a speech converted from the explanatory text, wherein the explanation generation unit stores the unconveyed information for the explanatory text as the conveyed information, stands by until completion of completion of the speech, and initiates a procedure for generating a new explanatory text based on updated unconveyed information.
    Type: Application
    Filed: May 23, 2018
    Publication date: February 27, 2020
    Applicants: NIPPON HOSO KYOKAI, NHK Engineering System, Inc.
    Inventors: Tadashi KUMANO, Ichiro YAMADA, Atsushi IMAI, Hideki SUMIYOSHI, Yuko YAMANOUCHI, Toshihiro SHIMIZU, Nobumasa SEIYAMA, Shoei SATO, Reiko SAITO, Taro MIYAZAKI, Kiyoshi KURIHARA, Manon ICHIKI, Tohru TAKAGI
  • Publication number: 20200017444
    Abstract: The present invention provides a heterocyclic compound having an orexin type 2 receptor agonist activity. A compound represented by the formula (I): wherein each symbol is as described in the specification, or a salt thereof, is useful as an agent for the prophylaxis or treatment of narcolepsy.
    Type: Application
    Filed: September 20, 2019
    Publication date: January 16, 2020
    Applicant: Takeda Pharmaceutical Company Limited
    Inventors: Yuichi KAJITA, Satoshi MIKAMI, Yuhei MIYANOHANA, Tatsuki KOIKE, Masaki DAINI, Norio OYABU, Masaki OGINO, Kohei TAKEUCHI, Yoshiteru ITO, Norihito TOKUNAGA, Takahiro SUGIMOTO, Tohru MIYAZAKI, Tsuneo ODA, Yasutaka HOASHI, Yasushi HATTORI, Keisuke IMAMURA
  • Patent number: 10444651
    Abstract: A carrier is provided including a core particle and a resin layer coating the surface of the core particle. The resin layer includes fine metal particles, and a detected metal element amount A obtained by X-ray photoelectron spectrometry of the surface of the carrier is in a range of 4.0 atomic %?A?20.0 atomic % and an average major-axis length B of the fine metal particle exposing from the resin layer is in a range of 100 nm?B?800 nm.
    Type: Grant
    Filed: March 5, 2018
    Date of Patent: October 15, 2019
    Assignee: Ricoh Company, Ltd.
    Inventors: Mariko Takii, Koichi Sakata, Tohru Suganuma, Masahiro Seki, Masashi Nagayama, Toyoaki Tano, Kohsuke Miyazaki
  • Patent number: 10435399
    Abstract: The present invention provides a heterocyclic compound having a HDAC inhibitory action, and useful for the treatment of central nervous system diseases including neurodegenerative disease, and the like, and a medicament comprising the compound. The present invention relates to a compound represented by the formula (I): wherein each symbol is as defined in the specification, or a salt thereof.
    Type: Grant
    Filed: July 30, 2018
    Date of Patent: October 8, 2019
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Masahiro Ito, Hideyuki Sugiyama, Osamu Kubo, Fumiaki Kikuchi, Takeshi Yasui, Keiko Kakegawa, Zenichi Ikeda, Tohru Miyazaki, Yasuyoshi Arikawa, Tomohiro Okawa, Jinichi Yonemori, Akinori Toita, Takuto Kojima, Yasutomi Asano, Ayumu Sato, Hironobu Maezaki, Shinobu Sasaki, Hironori Kokubo, Misaki Homma, Minoru Sasaki, Yasuhiro Imaeda
  • Patent number: 10428023
    Abstract: The present invention provides a heterocyclic compound having an orexin type 2 receptor agonist activity. A compound represented by the formula (I): wherein each symbol is as described in the specification, or a salt thereof, is useful as an agent for the prophylaxis or treatment of narcolepsy.
    Type: Grant
    Filed: August 2, 2018
    Date of Patent: October 1, 2019
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Yuichi Kajita, Yuhei Miyanohana, Tatsuki Koike, Kohei Takeuchi, Yoshiteru Ito, Norihito Tokunaga, Takahiro Sugimoto, Tohru Miyazaki, Tsuneo Oda, Yasutaka Hoashi, Yasushi Hattori, Keisuke Imamura
  • Publication number: 20190135799
    Abstract: The present invention provides a heterocyclic compound having a HDAC inhibitory action, and useful for the treatment of central nervous system diseases including neurodegenerative disease, and the like, and a medicament comprising the compound. The present invention relates to a compound represented by the formula (I): wherein each symbol is as defined in the specification, or a salt thereof.
    Type: Application
    Filed: July 30, 2018
    Publication date: May 9, 2019
    Inventors: Masahiro ITO, Hideyuki SUGIYAMA, Osamu KUBO, Fumiaki KIKUCHI, Takeshi YASUI, Keiko KAKEGAWA, Zenichi IKEDA, Tohru MIYAZAKI, Yasuyoshi ARIKAWA, Tomohiro OKAWA, Jinichi YONEMORI, Akinori TOITA, Takuto KOJIMA, Yasutomi ASANO, Ayumu SATO, Hironobu MAEZAKI, Shinobu SASAKI, Hironori KOKUBO, Misaki HOMMA, Minoru SASAKI, Yasuhiro IMAEDA
  • Publication number: 20190129907
    Abstract: A data transfer system includes a management server 1 for managing user information, browsing setting information that defines a user who can browse data, and transfer setting information that designates a transfer destination of the data, a data transfer apparatus 2 for setting, for the data, browsing authorization that allows only a specific user to browse the content of the data, based on the user information and the browsing setting information, and transferring the data for which the browsing authorization is set to the designated transfer destination based on the transfer setting information, and a data browsing apparatus 3 for determining whether or not a user has the browsing authorization that is set for the data, based on the user information, the browsing setting information, and the transfer setting information, and presenting the content of the data to the user if the user has the browsing authorization.
    Type: Application
    Filed: April 27, 2017
    Publication date: May 2, 2019
    Applicant: NEC Solution Innovators, Ltd.
    Inventor: Tohru MIYAZAKI
  • Publication number: 20190040010
    Abstract: The present invention provides a heterocyclic compound having an orexin type 2 receptor agonist activity. A compound represented by the formula (I): wherein each symbol is as described in the specification, or a salt thereof, is useful as an agent for the prophylaxis or treatment of narcolepsy.
    Type: Application
    Filed: August 2, 2018
    Publication date: February 7, 2019
    Applicant: Takeda Pharmaceutical Company Limited
    Inventors: Yuichi Kajita, Satoshi MIKAMI, Yuhei MIYANOHANA, Tatsuki KOIKE, Masaki DAINI, Norio OHYABU, Masaki OGINO, Kohei TAKEUCHI, Yoshiteru ITO, Norihito TOKUNAGA, Takahiro SUGIMOTO, Tohru MIYAZAKI, Tsuneo ODA, Yasutaka HOASHI, Yasushi HATTORI, Keisuke IMAMURA
  • Publication number: 20180132308
    Abstract: Provided is a wireless network construction apparatus capable of constructing a network according to which wireless communication terminals can efficiently and safely communicate. A wireless network construction apparatus is provided in a wireless communication terminal and constructs a wireless network with another wireless communication terminal.
    Type: Application
    Filed: March 29, 2016
    Publication date: May 10, 2018
    Applicant: NEC Solution Innovators, Ltd.
    Inventor: Tohru MIYAZAKI
  • Publication number: 20160019609
    Abstract: A cost computation apparatus (10) includes: a code clone detection unit (101) that detects, as a code clone, a set of identical or similar segments of pre-modification source code of a system; a componentization level setting unit (102) that sets a level at which the detected segments are integrated as a component; a post-modification source code estimation unit (103) that estimates post-modification source code obtained by applying componentization to the pre-modification source code at the set level; and a cost computation unit (104) that computes a modification cost required to update the system and a maintenance cost on the basis of the estimated post-modification source code in accordance with a computation standard that specifies a method of computing the modification cost and the maintenance cost.
    Type: Application
    Filed: February 25, 2014
    Publication date: January 21, 2016
    Inventor: Tohru MIYAZAKI
  • Publication number: 20130073880
    Abstract: A load measuring unit obtains load information on a configuring device. A status obtaining unit obtains status information of the configuring device based on the load information received from the load measuring unit. A learning unit learns actual power consumption based on actual power consumption received by a receiver unit, the load information obtained by the load measuring unit, and the status information obtained by the status obtaining unit. An estimating unit obtains estimated power consumption based on a learning result by the learning unit, the load information obtained by the load measuring unit, and the status information obtained by the status obtaining unit.
    Type: Application
    Filed: September 13, 2012
    Publication date: March 21, 2013
    Applicant: NEC System Technologies, Ltd.
    Inventor: Tohru MIYAZAKI